Comparisons of tumor-infiltrating lymphocyte levels and the 21-gene recurrence score in ER-positive/HER2-negative breast cancer

被引：0
|
作者：
Sung Gwe Ahn
Yoon Jin Cha
Soon June Bae
Chanik Yoon
Hak Woo Lee
Joon Jeong
机构：
[1] Yonsei University College of Medicine,Department of Surgery, Gangnam Severance Hospital
[2] Yonsei University College of Medicine,Department of Pathology, Gangnam Severance Hospital
来源：
BMC Cancer | / 18卷
关键词：
Tumor-infiltrating lymphocytes; 21-gene recurrence score; Breast cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Comparisons of tumor-infiltrating lymphocyte levels and the 21-gene recurrence score in ER-positive/HER2-negative breast cancer
    Ahn, Sung Gwe
    Cha, Yoon Jin
    Bae, Soon June
    Yoon, Chanik
    Lee, Hak Woo
    Jeong, Joon
    BMC CANCER, 2018, 18
  • [2] High Expression of NRF2 Is Associated with Increased Tumor-Infiltrating Lymphocytes and Cancer Immunity in ER-Positive/HER2-Negative Breast Cancer
    Oshi, Masanori
    Angarita, Fernando A.
    Tokumaru, Yoshihisa
    Yan, Li
    Matsuyama, Ryusei
    Endo, Itaru
    Takabe, Kazuaki
    CANCERS, 2020, 12 (12) : 1 - 15
  • [3] A 95-gene signature stratifies recurrence risk of invasive disease in ER-positive, HER2-negative, node-negative breast cancer with intermediate 21-gene signature recurrence scores
    Takeo Fujii
    Hiroko Masuda
    Yee Chung Cheng
    Fei Yang
    Aysegul A. Sahin
    Yasuto Naoi
    Yuki Matsunaga
    Akshara Raghavendra
    Arup Kumar Sinha
    Jose Rodrigo Espinosa Fernandez
    Anjali James
    Keisuke Yamagishi
    Tomoko Matsushima
    Robert Schuetz
    Debu Tripathy
    Sachiyo Tada
    Rubie S. Jackson
    Shinzaburo Noguchi
    Seigo Nakamura
    Jared D. Acoba
    Naoto T. Ueno
    Breast Cancer Research and Treatment, 2021, 189 : 455 - 461
  • [4] A 95-gene signature stratifies recurrence risk of invasive disease in ER-positive, HER2-negative, node-negative breast cancer with intermediate 21-gene signature recurrence scores
    Fujii, Takeo
    Masuda, Hiroko
    Cheng, Yee Chung
    Yang, Fei
    Sahin, Aysegul A.
    Naoi, Yasuto
    Matsunaga, Yuki
    Raghavendra, Akshara
    Sinha, Arup Kumar
    Fernandez, Jose Rodrigo Espinosa
    James, Anjali
    Yamagishi, Keisuke
    Matsushima, Tomoko
    Schuetz, Robert
    Tripathy, Debu
    Tada, Sachiyo
    Jackson, Rubie S.
    Noguchi, Shinzaburo
    Nakamura, Seigo
    Acoba, Jared D.
    Ueno, Naoto T.
    BREAST CANCER RESEARCH AND TREATMENT, 2021, 189 (02) : 455 - 461
  • [5] Association of tumor-infiltrating lymphocytes with recurrence score in hormone receptor-positive/HER2-negative breast cancer: Analysis of four prospective studies
    Miglietta, Federica
    Dieci, Maria Vittoria
    Giarratano, Tommaso
    Torri, Valter
    Giuliano, Mario
    Zustovich, Fable
    Mion, Marta
    Tondini, Carlo Alberto
    De Rossi, Costanza
    Bria, Emilio
    Franchi, Michela
    Merlini, Laura
    Giannatiempo, Rosa
    Russo, Daniela
    Fotia, Vittoria
    Poletti, Paola
    Caremoli, Elena Rota
    Arpino, Maria Grazia
    De Salvo, Gian Luca
    Zambelli, Alberto
    Guarneri, Valentina
    EUROPEAN JOURNAL OF CANCER, 2023, 195
  • [6] Elacestrant for ER-Positive HER2-Negative Advanced Breast Cancer
    Hageman, Elizabeth
    Lussier, Mia E.
    ANNALS OF PHARMACOTHERAPY, 2024, 58 (08) : 849 - 856
  • [7] Treatment Outcomes according to the EndoPredict Score in ER-Positive, HER2-Negative Early Breast Cancer
    Jung, Wonguen
    Kim, Kyubo
    Moon, Byung-In
    BREAST CARE, 2022, 17 (06) : 561 - 566
  • [8] 21-Gene Recurrence Score Assay Could Not Predict Benefit of Post-mastectomy Radiotherapy in T1-2 N1mic ER-Positive HER2-Negative Breast Cancer
    Zhang, Wen-Wen
    Tong, Qin
    Sun, Jia-Yuan
    Hua, Xin
    Long, Zhi-Qing
    Deng, Jia-Peng
    Dong, Yong
    Li, Fang-Yan
    He, Zhen-Yu
    Wu, San-Gang
    Lin, Huan-Xin
    FRONTIERS IN ONCOLOGY, 2019, 9
  • [9] The 21-gene recurrence score in node-positive, hormone receptor-positive, HER2-negative breast cancer: a cautionary tale from an NCDB analysis
    Weiser, Roi
    Haque, Waqar
    Polychronopoulou, Efstathia
    Hatch, Sandra S.
    Kuo, Yong-fang
    Gradishar, William J.
    Klimberg, V. Suzanne
    BREAST CANCER RESEARCH AND TREATMENT, 2021, 185 (03) : 667 - 676
  • [10] Implementing neoadjuvant endocrine strategies in ER-positive, HER2-negative breast cancer
    Matikas, Alexios
    Foukakis, Theodoros
    Michalakis, Ilias
    Georgoulias, Vassilis
    EXPERT REVIEW OF ANTICANCER THERAPY, 2017, 17 (04) : 319 - 326
12345